Reply To: Traders Market Weekly: Thanksgiving, a Time for Reflection

#47669
TradersCom
Keymaster

ImmunoGen Announce FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for the Treatment of Platinum-Resistant Ovarian Cancer

$IMGN 6.41▲ 0.65 (▲11.28%) After Hours